167 related articles for article (PubMed ID: 6450239)
1. Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines.
Zarling JM; Bach FH; Kung PC
J Immunol; 1981 Jan; 126(1):375-8. PubMed ID: 6450239
[TBL] [Abstract][Full Text] [Related]
2. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
3. Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations.
Zarling JM; Dierckins MS; Sevenich EA; Clouse KA
J Immunol; 1981 Nov; 127(5):2118-23. PubMed ID: 6170690
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
Tomkinson BE; Maziarz R; Sullivan JL
J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
[TBL] [Abstract][Full Text] [Related]
5. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
6. Two distinct human cloned T cell lines that exhibit natural killer-like and anti-human effector activities.
Sugamura K; Tanaka Y; Hinuma Y
J Immunol; 1982 Apr; 128(4):1749-52. PubMed ID: 6120975
[TBL] [Abstract][Full Text] [Related]
7. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
Hurrell SM; Zarling JM
J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
[TBL] [Abstract][Full Text] [Related]
8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
9. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
Tanaka Y; Sugamura K; Hinuma Y
J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
[TBL] [Abstract][Full Text] [Related]
11. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
[TBL] [Abstract][Full Text] [Related]
12. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
13. Generation of autoreactive cytotoxic lymphocytes by spontaneously established autologous lymphoblastoid cell line.
Sumiya M; Kano S; Gonda N; Oshimi K; Takaku F
J Immunol; 1980 Oct; 125(4):1625-9. PubMed ID: 6447729
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL) as stimulating cells in mixed lymphocyte culture (MLC).
Wasik M; Matej H; Duś D; Myc A
Arch Immunol Ther Exp (Warsz); 1983; 31(6):879-85. PubMed ID: 6331341
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human cytotoxic lymphocytes directed against cells infected with typhus group rickettsiae: evidence for lymphokine activation of effectors.
Carl M; Dasch GA
J Immunol; 1986 Apr; 136(7):2654-61. PubMed ID: 3081648
[TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
Thiele DL; Lipsky PE
J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
[TBL] [Abstract][Full Text] [Related]
17. Lysis of allogeneic human lymphocytes by nonspecifically activated T-like cells.
McMichael AJ; Gotch FM; Hildreth JE
Eur J Immunol; 1982 Dec; 12(12):1002-5. PubMed ID: 6984389
[TBL] [Abstract][Full Text] [Related]
18. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
19. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
20. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]